22.84
1.00%
-0.23
After Hours:
22.84
Olink Holding AB (publ) ADR stock is currently priced at $22.84, with a 24-hour trading volume of 78,698.
It has seen a -1.00% decreased in the last 24 hours and a -5.07% declined in the past month.
The chart indicates a potential bearish trend, as the stock is below the $22.86 pivot point. If it approaches the $22.66 support level, significant changes may occur.
Previous Close:
$23.07
Open:
$23.08
24h Volume:
78,698
Market Cap:
$2.84B
Revenue:
$169.60M
Net Income/Loss:
$-31.60M
P/E Ratio:
-163.14
EPS:
-0.14
Net Cash Flow:
$-51.24M
1W Performance:
+4.44%
1M Performance:
-5.07%
6M Performance:
-7.90%
1Y Performance:
+8.50%
Olink Holding AB (publ) ADR Stock (OLK) Company Profile
Name
Olink Holding AB (publ) ADR
Sector
Industry
Phone
46 1 8?4 44 39 70
Address
Uppsala Science Park, Uppsala
Olink Holding AB (publ) ADR Stock (OLK) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jan-05-23 | Initiated | Scotiabank | Sector Outperform |
Dec-14-22 | Initiated | Canaccord Genuity | Buy |
Apr-19-21 | Initiated | BTIG Research | Buy |
Apr-19-21 | Initiated | Goldman | Neutral |
Apr-19-21 | Initiated | Morgan Stanley | Equal-Weight |
Apr-19-21 | Initiated | SVB Leerink | Outperform |
View All
Olink Holding AB (publ) ADR Stock (OLK) Latest News
Report from the Annual General Meeting of Olink Holding AB (publ) on 19 April 2024
GlobeNewswire Inc.
ImmunoPrecise Antibodies Ltd. (IPA) Reports Q3 Loss, Tops Revenue Estimates
Zacks Investment Research
Olink announces change of date for Annual General Meeting
GlobeNewswire Inc.
Senseonics Holdings (SENS) Reports Q4 Loss, Tops Revenue Estimates
Zacks Investment Research
Forget Quantum-Si Stock, Olink Acquirer Thermo Fisher Is a Better Long-Term Investment
The Motley Fool
Company News for Nov 16, 2023
Zacks Investment Research
Olink Holding AB (publ) ADR Stock (OLK) Financials Data
Olink Holding AB (publ) ADR (OLK) Revenue 2024
OLK reported a revenue (TTM) of $169.60 million for the quarter ending December 31, 2023, a +21.27% rise year-over-year.
Olink Holding AB (publ) ADR (OLK) Net Income 2024
OLK net income (TTM) was -$31.60 million for the quarter ending December 31, 2023, a -145.90% decrease year-over-year.
Olink Holding AB (publ) ADR (OLK) Cash Flow 2024
OLK recorded a free cash flow (TTM) of -$51.24 million for the quarter ending December 31, 2023, a -32.70% decrease year-over-year.
Olink Holding AB (publ) ADR (OLK) Earnings per Share 2024
OLK earnings per share (TTM) was -$0.25 for the quarter ending December 31, 2023, a -150.00% decline year-over-year.
About Olink Holding AB (publ) ADR
Olink Holding AB (publ) provides various products and services for academic, government, biopharmaceutical, biotechnology, and other institutions focused on life science research. Its products include Olink Explore for cardiovascular and metabolic diseases, oncology, neurology, or inflammation; Olink Target product line; and Olink Focus product line consists of custom developed solutions for customers that have identified a small number of proteins of interest to focus on. The company's products also comprise Olink NPX Manager, a purpose-built software that enable users to import data, validate data quality, and normalize for subsequent statistical analysis; and Olink Insight, a cloud platform for data visualization and statistical analysis of normalized protein expression (NPX) data. In addition, it provides Olink Analysis services comprising study design and consultation, sample preparation and assay execution, and data processing and QC; and bioinformatics services. The company sells its products and services through its own direct sales force in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was formerly known as Knilo HoldCo AB and changed its name to Olink Holding AB (publ) in January 2021. Olink Holding AB (publ) was founded in 2016 and is headquartered in Uppsala, Sweden.
Cap:
|
Volume (24h):